107007-99-8结构式
Granisetron Hydrochloride
1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1h-indazole-3-carboxamid; endo-1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1h-indazole-3-carboxa; endo-monohydrochlorid; midehydrochloride; 1-METHYL-N-[(3-ENDO)-9-METHYL-9-AZABICYCLO[3.3.1]NON-3-YL]-1H-INDAZOLE-3-CARBOXAMIDE HYDROCHLORIDE; KYTRIL; BRL-43694A; GRANISERTROL HYDROCHLORIDE; GRANISETRON HCL; GRANISTRON HYDROCHLORIDE; GranisetronHclFda; GranisetronBase; GranisetronHydrochlorideFdaInspected; Granisertronhydrochloride; Granisetron hydrocholride; BRL-43694A, Kytril, 1-Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide Hydrochloride; 1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-, monohydrochloride, endo-; 1H-Indazole-3-carboxamide, 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-, monohydrochloride; endo-monohydrochloride; Gransetron HCl; Granisetron; Hyaluronic Acid; 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide; 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide hydrochloride (1:1); 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide
C18H24N4O
312.4094
532.016°C at 760 mmHg
0mmHg at 25°C
275.553°C
